CompletedNot Applicable

PAtient-CenTric Chronic Pancreatitis Registry (PACT-CP)

United States400 participantsStarted 2021-06-02

Plain-language summary

The main objective of this study is to generate real-world evidence reflecting the experience of individuals with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP). Efforts will be directed toward understanding the unmet need and therapeutic burden to identify the most critical factors that influence treatment choices/prescribing patterns, quality of life, and healthcare utilization outcomes in standard of care for individuals with EPI due to CP.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. At least 18 years of age (or age of majority)
. Willing to provide consent to participate
. Meet one (1) of the following at the time of enrollment:
. Diagnosis of chronic pancreatitis (CP)
. Diagnosis of recurrent acute pancreatitis (RAP)
. Suspected or confirmed diagnosis of EPI made by a healthcare provider
. On Pancreatic Enzyme Replacement Therapy (PERT), either prior to the Enrollment Visit or newly prescribed at the time of the Enrollment Visit.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Main Objective of the Study

Timeframe: Up to 5 years

Creation of a Patient Cohort

Timeframe: Up to 5 years

Disease History and Progression Data at Initial Visit

Timeframe: At Initial Visit

Progression Data (Every 3 months after Initial Visit)

Timeframe: Every 3 months after Initial Visit up to 5 years

Progression Data (Every 6 months after Initial Visit)

Timeframe: Every 6 months after Initial Visit up to 5 years

Clinical Care Practice Data at Initial Visit

Timeframe: At Initial Visit

Clinical Care Practice Data (Every 3 months after Initial Visit)

Timeframe: Every 3 months after Initial Visit up to 5 years

Trial details

NCT IDNCT05762445

SponsorCorEvitas

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2025-08-31

View on ClinicalTrials.gov More Chronic Pancreatitis trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. At least 18 years of age (or age of majority)
. Willing to provide consent to participate
. Meet one (1) of the following at the time of enrollment:
. Diagnosis of chronic pancreatitis (CP)
. Diagnosis of recurrent acute pancreatitis (RAP)
. Suspected or confirmed diagnosis of EPI made by a healthcare provider
. On Pancreatic Enzyme Replacement Therapy (PERT), either prior to the Enrollment Visit or newly prescribed at the time of the Enrollment Visit.

What they're measuring

Main Objective of the Study

Timeframe: Up to 5 years

Creation of a Patient Cohort

Timeframe: Up to 5 years

Disease History and Progression Data at Initial Visit

Timeframe: At Initial Visit

Progression Data (Every 3 months after Initial Visit)

Timeframe: Every 3 months after Initial Visit up to 5 years

Progression Data (Every 6 months after Initial Visit)

Timeframe: Every 6 months after Initial Visit up to 5 years

Clinical Care Practice Data at Initial Visit

Timeframe: At Initial Visit

Clinical Care Practice Data (Every 3 months after Initial Visit)

Timeframe: Every 3 months after Initial Visit up to 5 years